| RS1355372474 |
PKD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Polycystic kidney disease, Polycystic kidney disease 2 |
| RS1355372507 |
KMT2D
|
Health Risk |
Likely pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS1355377006 |
MYH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Aortic aneurysm |
| RS1355411201 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1355424790 |
DOK7
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 10, Fetal akinesia deformation sequence 1 |
| RS1355425067 |
LIAS
|
Health Risk |
Pathogenic |
Lipoic acid synthetase deficiency, Lipoic acid synthetase deficiency |
| RS1355448697 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1355457071 |
GNS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS1355461608 |
USH2A
|
Health Risk |
Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 36, Autosomal dominant nonsyndromic hearing loss 36 |
| RS1355467895 |
KIT
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS1355480465 |
UNC80
|
Health Risk |
Likely pathogenic |
Moderate global developmental delay, Moderate global developmental delay |
| RS1355492492 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS1355507329 |
TEX14
|
Health Risk |
Likely pathogenic |
Spermatogenic failure 23, Spermatogenic failure 23 |
| RS1355509467 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS1355535952 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1355555142 |
TNFRSF11B
|
Health Risk |
Likely pathogenic |
Hyperphosphatasemia with bone disease, Hyperphosphatasemia with bone disease |
| RS1355570425 |
PTEN
|
Health Risk |
Conflicting classifications of pathogenicity |
PTEN hamartoma tumor syndrome, Hereditary cancer-predisposing syndrome |
| RS1355576298 |
PTEN
|
Health Risk |
Conflicting classifications of pathogenicity |
PTEN hamartoma tumor syndrome, Hereditary cancer-predisposing syndrome |
| RS1355589374 |
ERCC4
|
Health Risk |
Pathogenic |
Cockayne syndrome, Fanconi anemia complementation group Q |
| RS1355589929 |
KANSL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |
| RS1355594941 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy |
| RS1355624192 |
TCAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2G, Hypertrophic cardiomyopathy 25 |
| RS1355632505 |
FTCD
|
Health Risk |
Likely pathogenic |
FTCD-related disorder, Sarcoma |
| RS1355649064 |
GLI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Pallister-Hall syndrome, Greig cephalopolysyndactyly syndrome |
| RS1355685453 |
EARS2
|
Health Risk |
Likely pathogenic |
Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome, Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome |
| RS1355690902 |
AHI1
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome, Retinal dystrophy |
| RS1355690953 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS1355691590 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1355697311 |
CTSC
|
Health Risk |
Conflicting classifications of pathogenicity |
Papillon-Lefèvre syndrome, Haim-Munk syndrome |
| RS1355715592 |
HGSNAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-III-C |
| RS1355716557 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Marfan syndrome |
| RS1355716761 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS1355731397 |
AHDC1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1355739310 |
ABAT
|
Health Risk |
Pathogenic/Likely pathogenic |
Gamma-aminobutyric acid transaminase deficiency, Gamma-aminobutyric acid transaminase deficiency |
| RS1355745932 |
SLC7A7
|
Health Risk |
Pathogenic/Likely pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS1355754530 |
DPYD
|
Health Risk |
Likely pathogenic |
Dihydropyrimidine dehydrogenase deficiency, Dihydropyrimidine dehydrogenase deficiency |
| RS1355760590 |
SDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS1355767159 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Intrauterine growth retardation, metaphyseal dysplasia |
| RS1355768631 |
CABP4
|
Health Risk |
Likely pathogenic |
— |
| RS1355781735 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS1355802816 |
PROM1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 41, Cone-rod dystrophy |
| RS1355804755 |
PEX16
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS1355806067 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS1355806716 |
NBAS
|
Health Risk |
Pathogenic/Likely pathogenic |
Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins, Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins |
| RS1355838837 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS1355856142 |
PREPL
|
Health Risk |
Pathogenic |
Myasthenic syndrome, congenital |
| RS1355878901 |
ERCC4
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group Q, Xeroderma pigmentosum |
| RS1355879925 |
CTNNA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1355900379 |
ZFYVE26
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Hereditary spastic paraplegia |
| RS1355905411 |
EVC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1355909028 |
RXYLT1
|
Health Risk |
Pathogenic |
— |
| RS1355966040 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS1355979496 |
RPE65
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 2, Retinitis pigmentosa 20 |
| RS1355988609 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1356000803 |
PC
|
Health Risk |
Likely pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS1356003109 |
LAMC2
|
Health Risk |
Pathogenic |
— |
| RS1356012723 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1356013382 |
GLI3
|
Health Risk |
Pathogenic |
Polysyndactyly 4, Polysyndactyly 4 |
| RS1356014648 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS1356068619 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1356073892 |
NAGS
|
Health Risk |
Likely pathogenic |
Hyperammonemia, type III |
| RS1356078500 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1356081271 |
COL5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS1356081968 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS1356090839 |
BLM
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Bloom syndrome |
| RS1356095864 |
APOB
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hypercholesterolemia, Familial hypobetalipoproteinemia 1 |
| RS1356103698 |
DDX41
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1356104318 |
ABCA4
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1356107030 |
SETX
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1356107537 |
RPGR
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Primary ciliary dyskinesia |
| RS1356107538 |
RAD50
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1356135634 |
CYP7B1
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1356136873 |
SMPD1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type B |
| RS1356154563 |
SAMHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS1356156358 |
SMARCE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial meningioma |
| RS1356166646 |
MTPAP
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1356183663 |
INF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease dominant intermediate E, Focal segmental glomerulosclerosis 5 |
| RS1356219990 |
ACAN
|
Health Risk |
Pathogenic/Likely pathogenic |
Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans |
| RS1356229958 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS1356231337 |
SMARCE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial meningioma, Hereditary cancer-predisposing syndrome |
| RS1356231878 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1356232517 |
UNC45A
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteootohepatoenteric syndrome, Cholestasis-edema syndrome |
| RS1356240181 |
CTNNA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary diffuse gastric adenocarcinoma, Patterned macular dystrophy 2 |
| RS1356246522 |
PAX3
|
Health Risk |
Pathogenic/Likely pathogenic |
Waardenburg syndrome type 1, PAX3-related disorder |
| RS1356254262 |
NKX2-5
|
Health Risk |
Conflicting classifications of pathogenicity |
Atrial septal defect 7, Atrial septal defect 7 |
| RS1356255450 |
SLC39A5
|
Health Risk |
Likely pathogenic |
Myopia 24, autosomal dominant |
| RS1356264344 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1356280167 |
PEX6
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 4A (Zellweger), Peroxisome biogenesis disorder 4B |
| RS1356287373 |
DSP
|
Health Risk |
Pathogenic |
Arrhythmogenic cardiomyopathy with wooly hair and keratoderma, Arrhythmogenic cardiomyopathy with wooly hair and keratoderma |
| RS1356317869 |
ABCC8
|
Health Risk |
Likely pathogenic |
— |
| RS1356329915 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Hurler syndrome |
| RS1356334936 |
HPS4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hermansky-Pudlak syndrome 4, Hermansky-Pudlak syndrome 4 |
| RS1356336963 |
PKP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 9, Arrhythmogenic right ventricular dysplasia 9 |
| RS1356340954 |
CAPN1
|
Health Risk |
Likely pathogenic |
Autosomal recessive spastic paraplegia type 76, Autosomal recessive spastic paraplegia type 76 |
| RS1356353167 |
LAMA3
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1356373737 |
ALOX12B
|
Health Risk |
Pathogenic |
Autosomal recessive congenital ichthyosis 2, Autosomal recessive congenital ichthyosis 2 |
| RS1356375715 |
GLDC
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycine encephalopathy, Glycine encephalopathy |
| RS1356378120 |
PKD1
|
Health Risk |
Likely pathogenic |
PKD1-related disorder, PKD1-related disorder |
| RS1356405952 |
KDM5A
|
Health Risk |
Likely pathogenic |
Intellectual disability, Seizure |
| RS1356426477 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, VISS syndrome |